Type:Notice
Citation:86 FR 4098
Reading Time:about 3 minutes
The Food and Drug Administration (FDA) is conducting a survey to gather information from facilities that manufacture, process, or pack drug products. This survey aims to understand how these facilities manage risks related to the quality of drug components, containers, and supply chains. The data collected will help the FDA analyze potential updates to manufacturing regulations for drugs. The public is invited to submit comments on this information collection by February 16, 2021.
Simple Explanation
The FDA wants to ask places that make drugs some questions to learn how they keep the drugs safe and good. They also want to make sure that anyone giving them answers knows that their information will be kept secret and safe.